ASLN ASLAN Pharmaceuticals Limited Stock Quote

ASLN [NASD]

Index	-	P/E	-	EPS (ttm)	-0.44	Insider Own	0.05%	Shs Outstand	70.69M	Perf Week	-11.43%
Market Cap	28.28M	Forward P/E	-	EPS next Y	-0.79	Insider Trans	0.00%	Shs Float	64.98M	Perf Month	-42.85%
Income	-21.30M	PEG	-	EPS next Q	-0.20	Inst Own	36.50%	Short Float	0.52%	Perf Quarter	-55.21%
Sales	-	P/S	-	EPS this Y	70.90%	Inst Trans	-5.53%	Short Ratio	1.77	Perf Half Y	-72.79%
Book/sh	1.08	P/B	0.37	EPS next Y	2.50%	ROA	-37.50%	Target Price	6.33	Perf Year	-86.93%
Cash/sh	1.33	P/C	0.30	EPS next 5Y	-	ROE	-63.80%	52W Range	0.40 - 3.87	Perf YTD	-64.29%
Dividend	-	P/FCF	-	EPS past 5Y	60.00%	ROI	-	52W High	-89.66%	Beta	2.41
Dividend %	-	Quick Ratio	18.50	Sales past 5Y	-	Gross Margin	-	52W Low	0.00%	ATR	0.06
Employees	18	Current Ratio	18.50	Sales Q/Q	-	Oper. Margin	-	RSI (14)	16.93	Volatility	12.48% 11.57%
Optionable	Yes	Debt/Eq	0.21	EPS Q/Q	25.30%	Profit Margin	-	Rel Volume	2.19	Prev Close	0.41
Shortable	Yes	LT Debt/Eq	0.20	Earnings	-	Payout	-	Avg Volume	191.52K	Price	0.40
Recom	2.00	SMA20	-24.04%	SMA50	-42.76%	SMA200	-71.41%	Volume	419,873	Change	-3.26%

Jul-09-21

Initiated

Jefferies

Buy

Jan-14-19

Reiterated

H.C. Wainwright

Buy

$12 → $8.50

May-20-22 07:00AM	ASLAN Pharmaceuticals Presents Late-Breaking Poster on Eblasakimab and Neuronal Itch Mechanisms at the 2022 Society for Investigative Dermatology Annual Meeting GlobeNewswire
May-18-22 07:00AM	ASLAN Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference GlobeNewswire
May-10-22 07:00AM	ASLAN Pharmaceuticals Announces Acceptance of Late-Breaking Abstract on Eblasakimab and Neuronal Itch Mechanisms for Poster Presentation at the 2022 Society for Investigative Dermatology Annual Meeting GlobeNewswire -6.02%
Apr-27-22 07:00AM	ASLAN Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update GlobeNewswire
Apr-06-22 07:00AM	ASLAN Pharmaceuticals to Present at the Annual Needham Virtual Healthcare Conference 2022 GlobeNewswire
Apr-01-22 05:00PM	ASLAN Pharmaceuticals Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement GlobeNewswire
Mar-28-22 07:00AM	ASLAN Pharmaceuticals Announces Late-Breaker Presentation of Data From Eblasakimab Proof-of-Concept Study at the 2022 American Academy of Dermatology Annual Meeting GlobeNewswire
Mar-25-22 07:00AM	ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update GlobeNewswire -6.22%
Mar-18-22 07:00AM	ASLAN Pharmaceuticals Announces Acceptance of Late-Breaking Abstract on Eblasakimab Proof-of-Concept Study in Atopic Dermatitis for Oral Presentation at the 2022 American Academy of Dermatology Annual Meeting GlobeNewswire
Mar-15-22 07:00AM	ASLAN Pharmaceuticals Appoints Dermatology Veteran Dr Alex Kaoukhov as Chief Medical Officer GlobeNewswire -9.03%
Jan-21-22 10:55AM	ASLAN (ASLN) Starts Phase IIb Study in Atopic Dermatitis Zacks
Jan-20-22 04:05PM	ASLAN Pharmaceuticals Initiates Phase 2b Study of ASLAN004 (Eblasakimab) in Moderate-to-Severe Atopic Dermatitis GlobeNewswire -5.03%
Jan-18-22 08:06AM	ASLAN Pharmaceuticals to Host New Episode in A4 KOL Series: Aspects of Atopic Dermatitis and ASLAN004 GlobeNewswire -8.33%
Jan-11-22 07:00AM	ASLAN Pharmaceuticals to Present Additional Data From Aslan004 Proof-Of-Concept Study at Two Upcoming Winter Dermatology Conferences GlobeNewswire
Jan-06-22 07:00AM	ASLAN Pharmaceuticals to Present at H.C. Wainwright Bioconnect Conference 2022 GlobeNewswire
Dec-06-21 07:00AM	ASLAN Pharmaceuticals and IQVIA Biotech Enter Into Strategic Collaboration GlobeNewswire +10.57%
Nov-22-21 07:00AM	ASLAN Pharmaceuticals Announces Participation at Two Upcoming Virtual Investor Conferences GlobeNewswire -5.59%
Nov-10-21 07:00AM	ASLAN Pharmaceuticals to Participate in Fireside Chat at the 12th Annual Jefferies London Healthcare Conference 2021 GlobeNewswire -6.01%
Oct-26-21 07:00AM	ASLAN Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update GlobeNewswire +9.35%
Oct-22-21 07:00AM	ASLAN Pharmaceuticals Announces Scientific Collaboration With Dr Emma Guttman-Yassky on Identification of ASLAN004-Specific Biomarkers GlobeNewswire -7.55%
Oct-18-21 07:00AM	ASLAN Pharmaceuticals Announces KOL Event Series to Discuss Atopic Dermatitis Treatment Landscape and ASLAN004 GlobeNewswire
Oct-14-21 07:00AM	ASLAN Pharmaceuticals Announces Expansion of Scientific Advisory Board With Appointment of Leading Global Experts in Dermatology and Immunology GlobeNewswire
Sep-28-21 10:11AM	10 Best Healthcare Stocks Under $20 According to Michael Castors Sio Capital Insider Monkey -8.49%
Sep-27-21 02:30PM	Mid-Afternoon Market Update: Dow Gains 150 Points; Red Cat Holdings Shares Spike Higher Benzinga -34.77%
12:11PM	Mid-Day Market Update: Crude Oil Rises 2%; ASLAN Pharmaceuticals Shares Slide Benzinga
10:15AM	Mid-Morning Market Update: Markets Mixed; US Durable Goods Orders Increase Sharply In August Benzinga
06:00AM	ASLAN Pharmaceuticals Announces Positive Data Conclusively Establishing Proof of Concept for ASLAN004 in Atopic Dermatitis GlobeNewswire
Sep-22-21 07:00AM	ASLAN Pharmaceuticals to Participate in the 2021 Cantor Virtual Global Healthcare Conference GlobeNewswire
Sep-21-21 07:00AM	ASLAN Pharmaceuticals Establishes Scientific Advisory Board Chaired by Distinguished Dermatology Expert Dr Lawrence Eichenfield GlobeNewswire
Sep-13-21 08:38AM	Implied Volatility Surging for ASLAN Pharmaceuticals (ASLN) Stock Options Zacks
Sep-09-21 07:00AM	ASLAN Pharmaceuticals to Present at H.C. Wainwright 23rd Annual Global Investment Conference GlobeNewswire
Aug-06-21 07:00AM	ASLAN Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update GlobeNewswire
Aug-04-21 07:00AM	ASLAN Pharmaceuticals to Participate in Fireside Chat at BTIG Virtual Biotechnology Conference GlobeNewswire
Jul-27-21 10:38PM	Were Hedge Funds Right About ASLAN Pharmaceuticals Limited (ASLN)? Insider Monkey
Jul-13-21 07:00AM	ASLAN Pharmaceuticals Announces Loan Facility Providing Up to $45 Million From K2 HealthVentures GlobeNewswire
Jul-09-21 06:08PM	Why ASLAN Pharmaceuticals Blasted Higher on Friday Motley Fool +7.91%
09:00AM	Singapore's Aslan Pharma Gets Buy Rating from Jefferies TheStreet.com
Jun-14-21 07:11AM	Crocs Is Breaking Out to a New All-Time High and It's My Stock of the Week TheStreet.com +17.72%
Jun-08-21 09:04AM	New Strong Sell Stocks for June 8th Zacks
Jun-04-21 09:04AM	New Strong Sell Stocks for June 4th Zacks
May-25-21 07:30AM	ASLAN Pharmaceuticals to Participate In Fireside Chat at Jefferies Virtual Healthcare Conference GlobeNewswire
May-11-21 07:30AM	ASLAN Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update GlobeNewswire
May-07-21 07:24AM	Epizyme's (EPZM) Q1 Earnings Miss, Revenues Beat Estimates Zacks
May-05-21 05:22AM	ASLAN Pharmaceuticals to Present Data on ASLAN004 at Society for Investigative Dermatology GlobeNewswire
Apr-30-21 09:24AM	Blueprint Medicines (BPMC) Q1 Earnings Beat, Revenues Lag Zacks
Apr-22-21 07:51AM	ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update GlobeNewswire
Apr-14-21 09:38AM	Gilead (GILD) Gets FDA Nod for Trodelvy in Urothelial Cancer Zacks
09:03AM	vTv Therapeutics (VTVT) Gets Breakthrough Tag for Diabetes Drug Zacks
Mar-18-21 07:27AM	ASLAN Pharmaceuticals Appoints Dr Kathleen Metters as Independent Director GlobeNewswire
Mar-10-21 12:00PM	What Makes ASLAN Pharmaceuticals Ltd. (ASLN) a New Buy Stock Zacks
Mar-04-21 02:47PM	Biotech Stock Roundup: REGN, VIR's COVID-19 Updates, KMPH's Drug Approval & More Zacks -15.13%
Mar-03-21 12:42AM	ASLAN Pharmaceuticals Announces Pricing of Public Offering of American Depositary Shares GlobeNewswire -9.51%
Mar-02-21 08:01AM	The Daily Biotech Pulse: Roxadustat Delay For FibroGen, AstraZeneca, Decision Day For KemPharm, NanoViricides Jumps On COVID-19 Drug Data Benzinga -17.90%
Mar-01-21 04:01PM	ASLAN Pharmaceuticals Announces Proposed Public Offering of American Depositary Shares GlobeNewswire +18.51%
08:18AM	Aslan Pharmaceuticals Shares Are Trading Higher On Positive ASLAN004 Data In Atopic Dermatitis Benzinga
06:00AM	ASLAN Pharmaceuticals Announces Positive Interim Data From the Multiple Ascending Dose Study of ASLAN004 in Atopic Dermatitis GlobeNewswire
05:13AM	Aslan Pharma Jumps on Progress With Dermatitis Treatment TheStreet.com
Feb-25-21 06:30AM	ASLAN Pharmaceuticals Announces $18 Million Private Placement GlobeNewswire +26.70%
Feb-18-21 07:00AM	ASLAN Pharmaceuticals Appoints Dr Neil Graham as Independent Director GlobeNewswire -7.35%
Jan-27-21 07:35AM	The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement Benzinga -6.00%
Jan-26-21 07:30AM	New Research Published in Toxicology in Vitro Provides Insight Into the Hepatotoxicity of DHODH Inhibitors Suggesting ASLAN003 Has the Potential to Be Best-In-Class GlobeNewswire +20.77%
Jan-11-21 05:34AM	ASLAN Pharmaceuticals Opens Expansion Cohort in ASLAN004 Atopic Dermatitis Clinical Trial GlobeNewswire
Jan-08-21 09:57AM	Alnylam (ALNY) Posts Positive Top-Line Data From Vutrisiran Study Zacks
Jan-06-21 11:13AM	REGENXBIO (RGNX) Provides Update on RGX-314 & Begins New Program Zacks
09:24AM	Aerpio (ARPO) Seeks Strategic Options for Pipeline Programs Zacks
Jan-04-21 09:34AM	Ultragenyx (RARE) Surges on Product Approvals, Pipeline Progress Zacks
Dec-30-20 11:25AM	Novo Nordisk (NVO) Files for Ozempic's Label Expansion in EU Zacks
Dec-25-20 12:00PM	ASLAN Pharmaceuticals Ltd. (ASLN) Moves to Buy: Rationale Behind the Upgrade Zacks
Dec-23-20 10:06AM	Roche's (RHHBY) Phesgo Gets EU Nod to Treat Breast Cancer Zacks
Dec-22-20 10:27AM	Jazz (JAZZ) Initiates BLA Submission for Leukemia Candidate Zacks
10:22AM	ChemoCentryx (CCXI) Reports Positive Top-Line Rare Disease Data Zacks
Dec-21-20 10:13AM	Novo Nordisk (NVO) Files for Semaglutide Label Expansion in EU Zacks
Dec-10-20 09:40AM	Ultragenyx (RARE) Gets Orphan Drug Tag for Wilson Disease Drug Zacks
Dec-03-20 10:04AM	CytoDyn (CYDY) Enrolls First Patient in NASH Study on Leronlimab Zacks
08:41AM	Intellia (NTLA) Catches Eye: Stock Jumps 7.8% Zacks
Dec-02-20 06:03PM	Acceleron (XLRN) Gets Orphan Drug Tag for ACE-1334 by FDA Zacks +10.43%
03:52PM	Amicus (FOLD) Initiates Rolling BLA Submission for AT-GAA Zacks
Dec-01-20 10:06AM	Verastem (VSTM) Begins Phase II Combo Study for Ovarian Cancer Zacks
10:04AM	Deciphera (DCPH) Ends Qinlock Second-Line GIST Study Enrollment Zacks
08:30AM	ORIC Pharmaceuticals (ORIC) in Focus: Stock Moves 6.7% Higher Zacks
Nov-29-20 08:24PM	Is ASLAN Pharmaceuticals Limited (ASLN) A Good Stock To Buy? Insider Monkey
Nov-27-20 08:25AM	HorizonTherapeutics (HZNP) Rises YTD on Approvals & Buyouts Zacks
Nov-24-20 03:10PM	Eiger (EIGR) Gets FDA Approval for Zokinvyin Rare Diseases Zacks
03:08PM	Horizon (HZNP) and Halozyme Ink Deal for ENHANZE Technology Zacks
03:07PM	Amgen (AMGN) Ends Deal With Cytokinetics for Heart Candidate Zacks
Nov-19-20 07:22AM	ASLAN Pharmaceuticals to Present at Upcoming Piper Sandler Investor Conference GlobeNewswire
Nov-18-20 11:24AM	Novo Nordisk's (NVO) Phase IIIb Study Meets Primary Endpoint Zacks
11:13AM	Alkermes (ALKS) Receives FDA CRL in Relation to ALKS 3831 Zacks
Nov-16-20 06:30AM	ASLAN Pharmaceuticals (ASLN) Sees Hammer Chart Pattern: Time to Buy? Zacks
Nov-09-20 07:00AM	ASLAN Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update GlobeNewswire +7.14%
Oct-22-20 07:30AM	ASLAN Pharmaceuticals Initiates Third Dose Cohort of ASLAN004 in Atopic Dermatitis Clinical Trial GlobeNewswire
Oct-19-20 10:05AM	ASLAN Pharmaceuticals (ASLN) in Focus: Stock Moves 7% Higher Zacks -7.32%
Oct-16-20 05:25AM	ASLAN Pharmaceuticals to Develop ASLAN003 as Next Generation DHODH Inhibitor in Autoimmune Conditions GlobeNewswire +7.33%
Sep-21-20 06:00AM	ASLAN Pharmaceuticals Completes Enrolment in Second Cohort and Opens New Sites in US and Australia in ASLAN004 Atopic Dermatitis Study GlobeNewswire
Sep-10-20 03:08AM	ASLAN Pharmaceuticals to Present at H.C. Wainwright 22nd Annual Global Investment Conference GlobeNewswire +7.04%
Aug-24-20 03:27AM	ASLAN Pharmaceuticals Resumes Recruitment of New Patients Into ASLAN004 Study GlobeNewswire
Aug-07-20 03:00AM	ASLAN Pharmaceuticals to Participate in Fireside Chat at BTIG Virtual Biotechnology Conference 2020 GlobeNewswire
Jul-17-20 06:08AM	ASLAN Pharmaceuticals Announces the Move of its Primary Listing to Nasdaq and Delisting From Taipei Exchange GlobeNewswire +10.27%
Jul-13-20 12:00PM	ASLAN Pharmaceuticals Ltd. (ASLN) Upgraded to Buy: Here's Why Zacks
08:06AM	ASLAN Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update GlobeNewswire

ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase for the treatment of autoimmune conditions. It has a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd. to develop immuno-oncology therapeutics for markets targeting the AhR pathway. Its partners include Almirall, Array BioPharma, and CSL Limited. The company was founded in 2010 and is headquartered in Singapore.

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience